XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
CURRENT ASSETS    
Cash and cash equivalents $ 2,237,624 $ 2,783,719
Accounts receivable 85,504 143,429
Inventory, net 421,324 242,630
Current portion of mortgage note receivable 39,061 39,061
Prepaid insurance and services 84,082 137,069
Prepaid clinical expenses 1,104,445 612,161
Total current assets 3,972,040 3,958,069
FURNITURE AND EQUIPMENT, NET 57,320 13,546
RIGHT-TO-USE LEASE ASSET, NET 38,348 51,017
MORTGAGE NOTE RECEIVABLE, LESS CURRENT PORTION 64,728 90,596
TOTAL ASSETS 4,132,436 4,113,228
CURRENT LIABILITIES    
Current portion of lease liability 14,378 16,385
Current portion of long-term debt 87,421
Accounts payable and accrued expenses 4,458,191 3,124,735
Total current liabilities 4,559,990 3,141,120
LONG-TERM LIABILITIES    
Long-term lease liability, less current portion 25,876 36,126
Long-term debt, less current portion 71,103
Total long-term liabilities 96,979 36,126
STOCKHOLDERS' EQUITY (DEFICIT)    
Common stock, par value $.0001 per share, 500,000,000 shares authorized, 169,876,130 and 121,564,990 shares issued and outstanding, at September 30, 2020 and December 31, 2019 16,987 12,155
Preferred stock, par value $.0001 per share, 5,000,000 shares authorized
Additional paid-in capital 30,840,706 26,044,060
Accumulated deficit (31,382,226) (25,120,233)
Total stockholders' equity (deficit) (524,533) 935,982
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) $ 4,132,436 $ 4,113,228